Are you Dr. Idell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11937 Us Highway 271
Tyler, TX 75708Phone+1 903-877-7777Fax+1 903-877-5838
Summary
- Dr. Steven Idell, MD is a pulmonologist in Tyler, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is affiliated with UT Health North Campus Tyler.
Education & Training
Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1983- Temple University HospitalResidency, Internal Medicine, 1977 - 1980
Lewis Katz School of Medicine at Temple UniversityClass of 1977
Certifications & Licensure
TX State Medical License 1985 - 2025
PA State Medical License 1979 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Myocardin regulates fibronectin expression and secretion from human pleural mesothelial cells.Tsuyoshi Sakai, Young-Yeon Choo, Shinya Mitsuhashi, Reiko Ikebe, Ann Jeffers
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-04-01 - Role of ZIP kinase in development of myofibroblast differentiation from HPMCs.Young-Yeon Choo, Tsuyoshi Sakai, Reiko Ikebe, Ann Jeffers, Steven Idell
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-03-01 - MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation.Xia Guo, Oluwaseun Adeyanju, Ayobami Matthew Olajuyin, Venkatakirankumar Mandlem, Christudas Sunil
American Journal of Physiology. Cell Physiology. 2023-11-01
Press Mentions
Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19September 9th, 2020
East Texas Researchers Studying More Effective Treatments for Cancer, Other Incurable DiseasesJanuary 30th, 2020- UTHSC: $1.4 Million Grant Renewal to Inspire Tuberculosis Research at Tyler Research CenterNovember 5th, 2019
- Join now to see all
Grant Support
- PAI-1 Targeted Intrapleural Fibronolytic TherapyNational Heart, Lung, And Blood Institute2011
- Fibrinolytic Pathways In Lung Injury And RepairNational Heart, Lung, And Blood Institute2005–2009
- Control Of Fibrin Turnover In Pleural DiseaseNational Heart, Lung, And Blood Institute2005–2009
- Administrative CoreNational Heart, Lung, And Blood Institute2005
- Control Of Fibrin Turnover In Pleural DiseaseNational Heart, Lung, And Blood Institute1991–2004
- Molecular Biology And Physiology Of Human Factor VIINational Heart, Lung, And Blood Institute1990–1992
- Lung Lavage Procoagulants In Lung Injury And RepairNational Heart, Lung, And Blood Institute1986–1990
